Glaucoma is an eye disease characterized by a pathological increase in intraocular pressure, due to the lack of drainage of the aqueous humor. This pressure may be reduced through pharmacological and surgical treatments.

When these don’t work, patients use implants with passive valves that allow for the draining of the aqueous humor. However, these implants can cause certain issues, such as fibrosis and unpredictable intraocular pressure, which can result in hypotonia and particle obstruction.

iMvalv provides the first active and intelligent ophthalmic device to regulate intraocular pressure in glaucoma patients. It is a microchip which is implanted to relieve the intraocular pressure in the eye, thus preventing blindness.